Project 3: Structural basis of amyloid formation and chaperone-mediated turnover

University Of California, San Francisco, San Francisco CA

Investigators

Linked publications & trials

Abstract

PROJECT SUMMARY Currently there are no known treatments that slow or prevent Alzheimer?s and other neurodegenerative diseases, and the molecular mechanisms that underlie the progression of these diseases are poorly understood. Our broad goal is to address critical problems in macromolecular structure determination of disease-relevant conformations of A? and tau prions and associated protein regulatory complexes in order to advance mechanistic understanding of prion propagation and guide novel therapeutic approaches. We will achieve this goal using high-resolution cryo-electron microscopy (cryo-EM) methods and: (1) Develop affinity capture methods on cryo-EM grids for extracting specific filaments from tissue for structure determination; (2) Determine cryo-EM structures of A? and tau fibril conformations derived from in vitro assembly and mouse models and compare with those determined from human tissue; and (3) Determine mechanisms and interactions by the Hsp70 molecular chaperone machinery that regulate prion propagation, ubiquitination, and clearance. With these goals we will identify the structural basis for amyloid fibrils that develop during disease and uncover key chaperone regulatory processes critical for quality control and clearance of proteins that form toxic amyloids.